A few of the molecules referenced do have FDA-approved products for specific indications (for example, semaglutide and tirzepatide for type 2 diabetes and chronic weight management, pentosan polysulfate sodium as ELMIRON for interstitial cystitis, and tesamorelin as Egrifta), though their use in this context may still be off-label or compounded
[DOI] [PubMed] [Google Scholar] 133.Luetic K., Sucic M., Vlainic J., Halle Z.B., Strinic D., Vidovic T., Luetic F., Marusic M., Gulic S., Pavelic T.T., et al
Dosage Protocols Beginner (Weeks 1-2) Dose : 150 mcg subQ Timing : Morning, fasted Frequency : Once daily Adaptation minimizes side effects
The optimal administration route in humans has not been definitively established through clinical trials